Equity-Based Compensation (Tables)

9 Months Ended

Sep. 30, 2026

Share-Based Payment Arrangement [Abstract]

Schedule of Share-Based Payment Arrangement, Option, Activity

The table below presents the activity and other information on the outstanding stock options:


	Stock Options Outstanding	Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contractual Life (in years)	Aggregate Intrinsic Value





























Outstanding as of December 31, 2025	1,735,338	$	2.80	7.56	$	4,684


Exercised	(43,430)	1.84

Expired	(158,915)	2.38
Outstanding as of September 30, 2026	1,532,993	$	2.85	7.14	$	725

Vested and exercisable as of September 30, 2026	1,145,969	$	2.75	6.77	$	717

					As of
					September 30, 2026
Unrecognized compensation costs related to the stock options					$	1,153
Weighted average recognition period for unrecognized compensation costs					2.20 years

Schedule of Share-Based Payment Arrangement, Restricted Stock Unit, Activity

The table below presents the activity and other information on the outstanding RSUs:


	RSUs Outstanding	Weighted-Average Grant Date Fair Value Per Share




















Unvested as of December 31, 2025	11,832,102	$	2.73
Granted	6,687,502	3.39
Vested	(4,653,188)	2.64
Forfeited	(1,144,518)	2.88
Unvested as of September 30, 2026	12,721,898	$	3.09

		As of
		September 30, 2026
Unrecognized compensation costs related to the RSUs		$	35,467
Weighted average recognition period for unrecognized compensation costs		2.64 years

Schedule of Share-Based Payment Arrangement, Performance Shares, Activity

The table below presents the activity and other information on the outstanding PSUs:


	PSUs Outstanding	Weighted-Average Grant Date Fair Value Per Share




















Unvested as of December 31, 2025	2,830,998	$	3.37

Vested	(1,040,410)	3.84
Forfeited	(1,790,588)	3.68
Unvested as of September 30, 2026	—	$	—

Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions

The table below presents the assumptions used to estimate the grant date fair value of the purchase rights under the ESPP:


	June 1, 2026			December 1, 2025

Price of common stock on the grant date	5.34			6.05
Expected term (in years)	0.50			0.50
Expected volatility(1)	110		%	110		%
Risk-free rate of return	3.8		%	3.8		%
Expected annual dividend yield	—		%	—		%

Fair value of the award on the grant date	$	2.44		$	2.76

(1) Expected volatility is based on a combination of implied and historical equity volatility of selected reasonably similar publicly traded companies.

Schedule of Share-Based Payment Arrangement, Expensed and Capitalized, Amount

The table below presents the total equity-based compensation expense recognized for Class B Units, Stock Options, RSUs, PSUs, and ESPP in selling, general and administrative expense, cost of revenues, and research and development for the following periods:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2026		2025		2026		2025
Equity-based compensation expense in selling, general and administrative	$	2,654	$	2,972	$	7,217	$	9,498
Equity-based compensation expense in cost of revenues	1,362		1,751		4,144		5,662
Equity-based compensation expense in research and development	608		598		1,429		1,880
Total equity-based compensation expense	$	4,624	$	5,321	$	12,790	$	17,040